Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$573.60 USD
+1.87 (0.33%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $573.31 -0.29 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
TMO 573.60 +1.87(0.33%)
Will TMO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMO
Company News for Apr 25, 2024
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Durable Goods Orders Came In Line With Expectations
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics
Other News for TMO
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity
Weitz Large Cap Equity Fund Q1 2024 Commentary
Thermo Fisher Outperforms in Q1 with Strong Revenue and Earnings Growth, Justifying Buy Rating
The Investment Case for Thermo Fisher Scientific Inc (TMO): How Financial Growth and Innovation ...
These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings